Related Experiment Video
Updated: Jun 7, 2025

09:35
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
13.2K
Increased QPCT gene expression by the hepatitis B virus promotes HBV replication
Conghui Zhang1,2, Qingfeng Ma3, Wei Wang4
1Department of Clinical Laboratory, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China.
Plos One
|November 12, 2024
Summary
Hepatitis B virus (HBV) infection promotes the expression of glutaminyl-peptide cyclotransferase (QPCT). This enzyme, in turn, enhances HBV replication and gene expression, revealing a novel regulatory loop in viral pathogenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Virology
Background:
- Glutamine cyclase, an enzyme crucial for posttranslational modifications, is encoded by the glutaminyl-peptide cyclotransferase (QPCT) gene.
- Previous research has not fully elucidated the role of QPCT in Hepatitis B virus (HBV) infection.
Purpose of the Study:
- To investigate the relationship between QPCT gene expression and HBV infection.
- To determine the effect of QPCT on HBV replication and expression.
Main Methods:
- Gene microarray analysis to compare QPCT expression in HepG2.2.15 and HepG2 cells.
- Enzyme-linked immunosorbent assay (ELISA) to measure serum QPCT levels in HBV-infected patients and healthy controls.
- Quantitative analysis of mRNA and protein expression of QPCT in HBV-expressing cell lines.
- Co-transfection experiments to assess the impact of QPCT on HBV replication markers.
Main Results:
- QPCT gene expression was significantly higher in HBV-infected patients' serum and in HBV-expressing cell lines compared to controls.
- Overexpression of QPCT in liver cells led to increased levels of HBV pgRNA, HBV-DNA copy number, HBeAg, and HBsAg.
- HBV infection was found to promote QPCT gene expression.
Conclusions:
- The study demonstrates a positive feedback loop where HBV promotes QPCT expression.
- QPCT, in turn, facilitates the expression and replication of HBV, suggesting it as a potential therapeutic target.

